Mwandishi:
Mhariri:
ULY CLINIC
Dkt. Benjamin L, MD
2 Aprili 2026, 11:46:06
Abacavir na ujauzito
Imeboreshwa:
Abacavir ni dawa ya kupunguza makali ya virusi vya UKIMWI iliyo kwenye kundi la dawa zinazoitwa NRTI. Dawa hii hutumika kutibu maambukizi ya HIV1. Dawa zingine zilizo kundi moja na abacavir ni didanosine, lamivudine, stavudine, zalcitabine, na zidovudine.
Ushauri wa matumizi kwa mama mjamzito
Inapatana na ujauzito kama faida kwa mama ni kubwa kuliko hatari kwa Kijusi-kichanga tumboni
Inapatana na ujauzito- faida kwa mama >>hatari kwa Kijusi-kichanga tumboni, ina maana gani?
Kunaweza kuwa au kutokuwa na uzoefu wa matumizi ya dawa hii kwa binadamu, lakini faida ni kubwa zaidi zikitumiwa na mama kuliko madhara yanayofahamika au kutofahamika kuwa yanaweza kutokea kwa kijusi-kichanganya tumboni. Kwa mama dawa zinazidi madhara yanayofahammika. Taarifa za uzazi kwa wanyama hazina mahusiano
Ushauri wa matumizi kwa mama anayenyonyesha
Haipatani na unyoyenyeshaji
Haipatani na unyoyenyeshaji, ina maana gani?
Kunawezekana kuwa hakuna taarifa za uzoefu wa matumizi ya dawa hii kwa mama anayenyonyesha. Hata hivyo mkusanyiko wa taarifa zinaonyesha kuwa dawa huweza kuwa sumu kali kwa kichanga, au haishauriwi kunyonyesha endapo dawa itahitajika kutumika kwa mama mwenye anayehitajika kutumia dawa hii. Mama anatakiwa asinyonyeshe anapotumia dawa hii au akiwa na ugonjwa unaotakiwa kutumia dawa hii.
ULY Clinic inakushauri uwasiliane na daktari wako siku zote kabla ya kufanya maamuzi yanayohusisha afya yako
Wasiliana na daktari wa ULY Clinic kwa ushauri na Tiba au kuandikiwa dawa kwa kutumia namba za simu au Kubonyeza Pata tiba chini ya tovuti hii.
Imeandikwa:
2 Aprili 2026, 11:41:58
Rejea za dawa
Townsend CL, Byrne L, Cortina-Borja M, Thorne C, de Ruiter A, Lyall H, et al. Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011. AIDS. 2014;28(7):1049-57.
Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States. Department of Health and Human Services; 2023. Available from: https://clinicalinfo.hiv.gov/en/guidelines/perinatal/whats-new-guidelines
Watts DH, Mofenson LM, Connick E, Benda N, Pitt J, Cotton MF, et al. Safety of Tenofovir Use During Pregnancy: Early Results from a Pregnancy Registry. J Acquir Immune Defic Syndr. 2013;62(1):e27-34.
Fenton T, Min SS, Maskew M, Boulle A, Sanne I, Myer L. Pregnancy Outcomes in HIV-Infected Women Receiving Combination Antiretroviral Therapy in South Africa: A Retrospective Cohort Study. J Acquir Immune Defic Syndr. 2018;77(2):e14-e21.
Ford N, Shubber Z, Pozniak A, Roy M, van der Lugt J, Haberer JE, et al. Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis. AIDS. 2014;28 Suppl 2:S123-31.
